SBC Medical Group (NASDAQ:SBC) Now Covered by BTIG Research

BTIG Research assumed coverage on shares of SBC Medical Group (NASDAQ:SBC) in a research note published on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $8.00 price objective on the stock.

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of SBC Medical Group in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, SBC Medical Group presently has an average rating of “Hold” and a consensus target price of $8.50.

SBC Medical Group Price Performance

Shares of NASDAQ SBC traded up $0.06 during midday trading on Friday, reaching $3.72. 37,968 shares of the stock traded hands, compared to its average volume of 25,291. The company’s 50 day moving average is $4.34 and its 200 day moving average is $4.09. SBC Medical Group has a one year low of $2.91 and a one year high of $5.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 5.10 and a quick ratio of 5.06. The stock has a market capitalization of $381.60 million, a PE ratio of 9.07 and a beta of 1.19.

Institutional Investors Weigh In On SBC Medical Group

Several institutional investors have recently modified their holdings of the stock. Wells Fargo & Company MN boosted its holdings in shares of SBC Medical Group by 195.1% in the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock worth $54,000 after purchasing an additional 8,348 shares during the period. Russell Investments Group Ltd. raised its holdings in SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock valued at $51,000 after buying an additional 8,771 shares during the period. Barclays PLC lifted its position in SBC Medical Group by 123.7% in the fourth quarter. Barclays PLC now owns 17,779 shares of the company’s stock worth $77,000 after buying an additional 9,831 shares during the last quarter. Goldman Sachs Group Inc. purchased a new position in SBC Medical Group during the fourth quarter worth $49,000. Finally, Nuveen LLC purchased a new position in SBC Medical Group during the fourth quarter worth $53,000. 60.82% of the stock is owned by institutional investors.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.